Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sanqi huayu xingnao + zhilong huoxue tongyu
- Development stage
- Preclinical
- Lead developer
- Hospital of Traditional Chinese Medicine Affiliated to Southwest Medical University
- Modality
- Peptides, Small Molecules
- Administration
- Intravenous, Oral
01
Overview
SXHYXN + ZLHXTY is a combination therapy consisting of two Traditional Chinese Medicine (TCM) formulations: Sanqi Huayu Xingnao (SXHYXN) and Zhilong Huoxue Tongyu (ZLHXTY). Developed by the Hospital of Traditional Chinese Medicine affiliated to Southwest Medical University, this combination is primarily used for the treatment of hypertensive intracerebral hemorrhage (HICH). SXHYXN is typically administered as an injection containing extracts from *Panax notoginseng* (Sanqi), which provides neuroprotective and anti-inflammatory effects while promoting the resolution of blood stasis. ZLHXTY is formulated as a capsule containing animal-derived components such as *Hirudo* (leech) and *Lumbricus* (earthworm), which contain hirudin and other enzymes that act as potent thrombin inhibitors. Together, these formulations aim to accelerate hematoma absorption, reduce peri-hematomal edema, and improve neurological recovery in patients following a cerebral hemorrhage.
- Other names
- Sanqi Huayu Xingnao Injection + Zhilong Huoxue Tongyu Capsule三七化瘀醒脑注射液 + 蛭龙活血通瘀胶囊
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))F2 (Thrombin)
Beyond the preview
Go deeper on sanqi huayu xingnao + zhilong huoxue tongyu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sanqi huayu xingnao + zhilong huoxue tongyu.